永安藥業(002365.SZ)取得歐洲專利證書 涉一種高收率循環生產牛磺酸的方法
格隆匯10月31日丨永安藥業(002365.SZ)公佈,近日,公司收到歐洲專利局頒發的專利證書,涉一種高收率循環生產牛磺酸的方法。
此次取得證書與2019年中國國家知識產權局頒發的專利證書《一種高收率循環生產牛磺酸的方法》、2019年日本專利局頒發的專利證書《一種高收率循環生產牛磺酸的方法》、2018年美國專利及商標局頒發的專利證書《一種高收率循環生產牛磺酸的方法》同為一種方法。
該專利已應用於公司牛磺酸生產,有利於降低牛磺酸生產成本,有助於提高生產穩定性和產品質量。公司為全球牛磺酸領域的知名企業,一直致力於牛磺酸生產技術的研發,通過不斷加強知識產權保護,進一步提升公司牛磺酸產品在國際市場的競爭力和知名度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.